Grant: CIHR Fellowship
University of Toronto
$90,000.00
Magnetic Seizure Therapy for the Treatment of Treatment-Resistant Depression and Suicidality in Borderline Personality Disorder
EF 2018-19
Résumé
Borderline personality disorder (BPD) is a severe mental health disorder with one of the highest rates of suicide among all psychiatric illnesses. About 1 in 10 persons with BPD dies by suicide, which is 50 times greater than the rate of suicide in the general population. A new brain stimulation therapy called magnetic seizure therapy (MST) is a safe and effective treatment for people with treatment-resistant depression, and produces substantial reductions in suicidal thinking in about 75% patients. Given the high rates of suicidal thinking and depression-related symptoms in individuals with BPD, MST could also be an effective treatment for these individuals, but has never been studied in this population. Our research group is conducting an ongoing Health Canada-approved pilot study investigating the effectiveness of conjoint MST plus psychotherapy, compared to psychotherapy alone, for treatment-resistant depression and suicidal thinking in patients with BPD. Brain imaging scans are acquired before and after treatment to examine brain changes in each treatment group. In the proposed study, I continue to recruit an additional 10 patients in order to complete the pilot study, and I analyze pre- and post-treatment brain scans. I hypothesize that the MST treatment group will show greater reductions in suicidal thinking and depression, and that these changes will correspond with an increase in brain functional connectivity between brain areas involved in the control of emotion (i.e., the prefrontal cortex and limbic system). This is the first ever study to investigate the feasibility of brain stimulation therapy for suicidal patients with treatment-resistant depression and BPD. This research could identify a safe and effective treatment for patients with BPD that require more intensive intervention, ultimately helping to prevent loss of life in patients who do not respond to first-line treatments.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
396196
Name
Traynor Jenna M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Health Research Training B - HP
Projecttitle
Magnetic Seizure Therapy for the Treatment of Treatment-Resistant Depression and Suicidality in Borderline Personality Disorder
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Borderline Personality Disorder; Depression; Functional Magnetic Resonance Imaging; Magnetic Seizure Therapy; Neuroimaging; Suicide
Abstract
Borderline personality disorder (BPD) is a severe mental health disorder with one of the highest rates of suicide among all psychiatric illnesses. About 1 in 10 persons with BPD dies by suicide, which is 50 times greater than the rate of suicide in the general population. A new brain stimulation therapy called magnetic seizure therapy (MST) is a safe and effective treatment for people with treatment-resistant depression, and produces substantial reductions in suicidal thinking in about 75% patients. Given the high rates of suicidal thinking and depression-related symptoms in individuals with BPD, MST could also be an effective treatment for these individuals, but has never been studied in this population. Our research group is conducting an ongoing Health Canada-approved pilot study investigating the effectiveness of conjoint MST plus psychotherapy, compared to psychotherapy alone, for treatment-resistant depression and suicidal thinking in patients with BPD. Brain imaging scans are acquired before and after treatment to examine brain changes in each treatment group. In the proposed study, I continue to recruit an additional 10 patients in order to complete the pilot study, and I analyze pre- and post-treatment brain scans. I hypothesize that the MST treatment group will show greater reductions in suicidal thinking and depression, and that these changes will correspond with an increase in brain functional connectivity between brain areas involved in the control of emotion (i.e., the prefrontal cortex and limbic system). This is the first ever study to investigate the feasibility of brain stimulation therapy for suicidal patients with treatment-resistant depression and BPD. This research could identify a safe and effective treatment for patients with BPD that require more intensive intervention, ultimately helping to prevent loss of life in patients who do not respond to first-line treatments.
Competitiondate
201811
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Traynor, Jenna M
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~